nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—CXCR1—melanoma	0.35	0.688	CbGaD
Diclofenac—CXCL8—melanoma	0.0885	0.174	CbGaD
Diclofenac—ABCC1—Vemurafenib—melanoma	0.0577	0.206	CbGbCtD
Diclofenac—ABCC1—Dactinomycin—melanoma	0.0383	0.137	CbGbCtD
Diclofenac—CYP1A1—Dacarbazine—melanoma	0.0273	0.0977	CbGbCtD
Diclofenac—ALB—Vemurafenib—melanoma	0.0266	0.0952	CbGbCtD
Diclofenac—PTGS2—melanoma	0.0258	0.0506	CbGaD
Diclofenac—ALB—melanoma	0.023	0.0451	CbGaD
Diclofenac—ABCB1—melanoma	0.0219	0.043	CbGaD
Diclofenac—CYP2E1—Dacarbazine—melanoma	0.0211	0.0755	CbGbCtD
Diclofenac—CYP1A2—Carmustine—melanoma	0.0201	0.072	CbGbCtD
Diclofenac—ABCC1—Docetaxel—melanoma	0.0198	0.0708	CbGbCtD
Diclofenac—CYP1A2—Vemurafenib—melanoma	0.0159	0.0569	CbGbCtD
Diclofenac—CYP3A4—Temozolomide—melanoma	0.0152	0.0544	CbGbCtD
Diclofenac—CYP1A2—Dacarbazine—melanoma	0.0122	0.0436	CbGbCtD
Diclofenac—ABCB1—Dactinomycin—melanoma	0.00925	0.0331	CbGbCtD
Diclofenac—CYP3A4—Vemurafenib—melanoma	0.00834	0.0298	CbGbCtD
Diclofenac—ABCB1—Docetaxel—melanoma	0.00478	0.0171	CbGbCtD
Diclofenac—CYP3A4—Docetaxel—melanoma	0.00286	0.0102	CbGbCtD
Diclofenac—SLC22A8—optic choroid—melanoma	0.00139	0.0815	CbGeAlD
Diclofenac—KCNQ2—eye—melanoma	0.000735	0.043	CbGeAlD
Diclofenac—PTGS2—leg—melanoma	0.0007	0.041	CbGeAlD
Diclofenac—CXCR1—lymph node—melanoma	0.000671	0.0393	CbGeAlD
Diclofenac—PTGS2—hindlimb—melanoma	0.000625	0.0366	CbGeAlD
Diclofenac—TTR—neck—melanoma	0.000614	0.036	CbGeAlD
Diclofenac—ASIC1—head—melanoma	0.00057	0.0334	CbGeAlD
Diclofenac—PTGS2—appendage—melanoma	0.000536	0.0314	CbGeAlD
Diclofenac—CYP1A1—skin epidermis—melanoma	0.000531	0.0311	CbGeAlD
Diclofenac—ABCC1—hair follicle—melanoma	0.000482	0.0282	CbGeAlD
Diclofenac—PLA2G2A—mammalian vulva—melanoma	0.00048	0.0281	CbGeAlD
Diclofenac—TTR—eye—melanoma	0.000457	0.0268	CbGeAlD
Diclofenac—KCNQ3—head—melanoma	0.000453	0.0266	CbGeAlD
Diclofenac—TTR—retina—melanoma	0.000453	0.0265	CbGeAlD
Diclofenac—PTGS2—skin epidermis—melanoma	0.000446	0.0261	CbGeAlD
Diclofenac—CYP2C18—mammalian vulva—melanoma	0.000438	0.0257	CbGeAlD
Diclofenac—KCNQ2—head—melanoma	0.000417	0.0244	CbGeAlD
Diclofenac—ASIC1—lymph node—melanoma	0.000399	0.0234	CbGeAlD
Diclofenac—PLA2G2A—head—melanoma	0.000344	0.0201	CbGeAlD
Diclofenac—PTGS1—endothelium—melanoma	0.000339	0.0198	CbGeAlD
Diclofenac—PTGS2—endothelium—melanoma	0.000324	0.019	CbGeAlD
Diclofenac—PTGS1—blood vessel—melanoma	0.000312	0.0183	CbGeAlD
Diclofenac—PTGS2—blood vessel—melanoma	0.000299	0.0175	CbGeAlD
Diclofenac—SLCO1C1—head—melanoma	0.00029	0.017	CbGeAlD
Diclofenac—SLC22A8—eye—melanoma	0.00028	0.0164	CbGeAlD
Diclofenac—SCN4A—head—melanoma	0.000267	0.0156	CbGeAlD
Diclofenac—Bromfenac—PTGS2—melanoma	0.000262	0.232	CrCbGaD
Diclofenac—TTR—head—melanoma	0.000259	0.0152	CbGeAlD
Diclofenac—PLA2G2A—lymph node—melanoma	0.000241	0.0141	CbGeAlD
Diclofenac—CXCL8—lymph node—melanoma	0.000238	0.0139	CbGeAlD
Diclofenac—ALOX5—head—melanoma	0.000235	0.0138	CbGeAlD
Diclofenac—Lumiracoxib—PTGS2—melanoma	0.000223	0.198	CrCbGaD
Diclofenac—Nepafenac—PTGS2—melanoma	0.000212	0.188	CrCbGaD
Diclofenac—SLCO1C1—lymph node—melanoma	0.000203	0.0119	CbGeAlD
Diclofenac—ABCC1—mammalian vulva—melanoma	0.000191	0.0112	CbGeAlD
Diclofenac—ABCB1—blood vessel—melanoma	0.000185	0.0108	CbGeAlD
Diclofenac—Meclofenamic acid—PTGS2—melanoma	0.000174	0.154	CrCbGaD
Diclofenac—CYP1A1—skin of body—melanoma	0.000165	0.00964	CbGeAlD
Diclofenac—ALOX5—lymph node—melanoma	0.000165	0.00964	CbGeAlD
Diclofenac—ABCC4—head—melanoma	0.00016	0.00939	CbGeAlD
Diclofenac—CYP2B6—skin of body—melanoma	0.00016	0.00937	CbGeAlD
Diclofenac—SLC22A8—head—melanoma	0.000159	0.00931	CbGeAlD
Diclofenac—CYP1A1—mammalian vulva—melanoma	0.00015	0.00879	CbGeAlD
Diclofenac—PTGS1—skin of body—melanoma	0.000145	0.00847	CbGeAlD
Diclofenac—PTGS2—skin of body—melanoma	0.000138	0.00809	CbGeAlD
Diclofenac—Mefenamic acid—PTGS2—melanoma	0.000135	0.12	CrCbGaD
Diclofenac—PTGS1—mammalian vulva—melanoma	0.000132	0.00772	CbGeAlD
Diclofenac—Clonidine—ABCB1—melanoma	0.000122	0.108	CrCbGaD
Diclofenac—ALB—lymph node—melanoma	0.000116	0.00679	CbGeAlD
Diclofenac—Myalgia—Bleomycin—melanoma	0.000113	0.00128	CcSEcCtD
Diclofenac—Chest pain—Bleomycin—melanoma	0.000113	0.00128	CcSEcCtD
Diclofenac—Abdominal pain upper—Docetaxel—melanoma	0.000113	0.00128	CcSEcCtD
Diclofenac—Rash—Vemurafenib—melanoma	0.000113	0.00128	CcSEcCtD
Diclofenac—Mental disorder—Temozolomide—melanoma	0.000113	0.00128	CcSEcCtD
Diclofenac—Dermatitis—Vemurafenib—melanoma	0.000113	0.00128	CcSEcCtD
Diclofenac—ABCC4—lymph node—melanoma	0.000112	0.00657	CbGeAlD
Diclofenac—Back pain—Carmustine—melanoma	0.000112	0.00127	CcSEcCtD
Diclofenac—Headache—Vemurafenib—melanoma	0.000112	0.00127	CcSEcCtD
Diclofenac—Malnutrition—Temozolomide—melanoma	0.000112	0.00127	CcSEcCtD
Diclofenac—Erythema—Temozolomide—melanoma	0.000112	0.00127	CcSEcCtD
Diclofenac—Discomfort—Bleomycin—melanoma	0.000112	0.00127	CcSEcCtD
Diclofenac—Malaise—Dactinomycin—melanoma	0.000112	0.00127	CcSEcCtD
Diclofenac—Aspartate aminotransferase increased—Docetaxel—melanoma	0.000111	0.00126	CcSEcCtD
Diclofenac—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000111	0.00126	CcSEcCtD
Diclofenac—Cramp muscle—Docetaxel—melanoma	0.000111	0.00126	CcSEcCtD
Diclofenac—Leukopenia—Dactinomycin—melanoma	0.000111	0.00126	CcSEcCtD
Diclofenac—Nasopharyngitis—Docetaxel—melanoma	0.000111	0.00125	CcSEcCtD
Diclofenac—Dysgeusia—Temozolomide—melanoma	0.00011	0.00124	CcSEcCtD
Diclofenac—Confusional state—Bleomycin—melanoma	0.000109	0.00124	CcSEcCtD
Diclofenac—Vision blurred—Carmustine—melanoma	0.000109	0.00124	CcSEcCtD
Diclofenac—Alanine aminotransferase increased—Docetaxel—melanoma	0.000109	0.00124	CcSEcCtD
Diclofenac—Tremor—Carmustine—melanoma	0.000109	0.00123	CcSEcCtD
Diclofenac—Oedema—Bleomycin—melanoma	0.000108	0.00123	CcSEcCtD
Diclofenac—Anaphylactic shock—Bleomycin—melanoma	0.000108	0.00123	CcSEcCtD
Diclofenac—Back pain—Temozolomide—melanoma	0.000108	0.00123	CcSEcCtD
Diclofenac—Infection—Bleomycin—melanoma	0.000108	0.00122	CcSEcCtD
Diclofenac—CYP1A1—head—melanoma	0.000107	0.00629	CbGeAlD
Diclofenac—Anaemia—Carmustine—melanoma	0.000107	0.00121	CcSEcCtD
Diclofenac—Agitation—Carmustine—melanoma	0.000106	0.00121	CcSEcCtD
Diclofenac—Nausea—Vemurafenib—melanoma	0.000106	0.0012	CcSEcCtD
Diclofenac—Thrombocytopenia—Bleomycin—melanoma	0.000106	0.0012	CcSEcCtD
Diclofenac—Vision blurred—Temozolomide—melanoma	0.000106	0.0012	CcSEcCtD
Diclofenac—Myalgia—Dactinomycin—melanoma	0.000105	0.00119	CcSEcCtD
Diclofenac—Bronchospasm—Docetaxel—melanoma	0.000105	0.00119	CcSEcCtD
Diclofenac—Tremor—Temozolomide—melanoma	0.000105	0.00119	CcSEcCtD
Diclofenac—CYP2B6—head—melanoma	0.000104	0.00611	CbGeAlD
Diclofenac—Discomfort—Dactinomycin—melanoma	0.000104	0.00118	CcSEcCtD
Diclofenac—Angina pectoris—Docetaxel—melanoma	0.000104	0.00118	CcSEcCtD
Diclofenac—Ill-defined disorder—Temozolomide—melanoma	0.000104	0.00118	CcSEcCtD
Diclofenac—Leukopenia—Carmustine—melanoma	0.000104	0.00118	CcSEcCtD
Diclofenac—Anaemia—Temozolomide—melanoma	0.000103	0.00117	CcSEcCtD
Diclofenac—Anorexia—Bleomycin—melanoma	0.000103	0.00117	CcSEcCtD
Diclofenac—Agitation—Temozolomide—melanoma	0.000103	0.00117	CcSEcCtD
Diclofenac—Angioedema—Temozolomide—melanoma	0.000102	0.00116	CcSEcCtD
Diclofenac—Pancytopenia—Docetaxel—melanoma	0.000101	0.00115	CcSEcCtD
Diclofenac—Hypotension—Bleomycin—melanoma	0.000101	0.00115	CcSEcCtD
Diclofenac—Oedema—Dactinomycin—melanoma	0.000101	0.00115	CcSEcCtD
Diclofenac—Malaise—Temozolomide—melanoma	0.000101	0.00114	CcSEcCtD
Diclofenac—Vertigo—Temozolomide—melanoma	0.000101	0.00114	CcSEcCtD
Diclofenac—Convulsion—Carmustine—melanoma	0.0001	0.00114	CcSEcCtD
Diclofenac—Infection—Dactinomycin—melanoma	0.0001	0.00114	CcSEcCtD
Diclofenac—Leukopenia—Temozolomide—melanoma	0.0001	0.00114	CcSEcCtD
Diclofenac—Hypertension—Carmustine—melanoma	0.0001	0.00113	CcSEcCtD
Diclofenac—Palpitations—Temozolomide—melanoma	9.89e-05	0.00112	CcSEcCtD
Diclofenac—Thrombocytopenia—Dactinomycin—melanoma	9.89e-05	0.00112	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Bleomycin—melanoma	9.87e-05	0.00112	CcSEcCtD
Diclofenac—Myalgia—Carmustine—melanoma	9.86e-05	0.00112	CcSEcCtD
Diclofenac—Chest pain—Carmustine—melanoma	9.86e-05	0.00112	CcSEcCtD
Diclofenac—Anxiety—Carmustine—melanoma	9.83e-05	0.00111	CcSEcCtD
Diclofenac—CYP2E1—head—melanoma	9.79e-05	0.00574	CbGeAlD
Diclofenac—Cough—Temozolomide—melanoma	9.77e-05	0.00111	CcSEcCtD
Diclofenac—ABCB1—retina—melanoma	9.74e-05	0.0057	CbGeAlD
Diclofenac—Paraesthesia—Bleomycin—melanoma	9.73e-05	0.0011	CcSEcCtD
Diclofenac—Weight increased—Docetaxel—melanoma	9.72e-05	0.0011	CcSEcCtD
Diclofenac—Convulsion—Temozolomide—melanoma	9.7e-05	0.0011	CcSEcCtD
Diclofenac—Weight decreased—Docetaxel—melanoma	9.67e-05	0.0011	CcSEcCtD
Diclofenac—Hypertension—Temozolomide—melanoma	9.67e-05	0.0011	CcSEcCtD
Diclofenac—Dyspnoea—Bleomycin—melanoma	9.66e-05	0.00109	CcSEcCtD
Diclofenac—Anorexia—Dactinomycin—melanoma	9.63e-05	0.00109	CcSEcCtD
Diclofenac—Pneumonia—Docetaxel—melanoma	9.58e-05	0.00109	CcSEcCtD
Diclofenac—ABCC1—lymph node—melanoma	9.57e-05	0.0056	CbGeAlD
Diclofenac—Confusional state—Carmustine—melanoma	9.53e-05	0.00108	CcSEcCtD
Diclofenac—Arthralgia—Temozolomide—melanoma	9.53e-05	0.00108	CcSEcCtD
Diclofenac—Myalgia—Temozolomide—melanoma	9.53e-05	0.00108	CcSEcCtD
Diclofenac—Infestation—Docetaxel—melanoma	9.53e-05	0.00108	CcSEcCtD
Diclofenac—Infestation NOS—Docetaxel—melanoma	9.53e-05	0.00108	CcSEcCtD
Diclofenac—Anxiety—Temozolomide—melanoma	9.5e-05	0.00108	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	9.47e-05	0.00107	CcSEcCtD
Diclofenac—Oedema—Carmustine—melanoma	9.45e-05	0.00107	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Docetaxel—melanoma	9.45e-05	0.00107	CcSEcCtD
Diclofenac—PTGS1—head—melanoma	9.43e-05	0.00553	CbGeAlD
Diclofenac—Discomfort—Temozolomide—melanoma	9.42e-05	0.00107	CcSEcCtD
Diclofenac—Decreased appetite—Bleomycin—melanoma	9.42e-05	0.00107	CcSEcCtD
Diclofenac—Infection—Carmustine—melanoma	9.39e-05	0.00106	CcSEcCtD
Diclofenac—Acute coronary syndrome—Docetaxel—melanoma	9.39e-05	0.00106	CcSEcCtD
Diclofenac—Renal failure—Docetaxel—melanoma	9.37e-05	0.00106	CcSEcCtD
Diclofenac—Neuropathy peripheral—Docetaxel—melanoma	9.34e-05	0.00106	CcSEcCtD
Diclofenac—Myocardial infarction—Docetaxel—melanoma	9.34e-05	0.00106	CcSEcCtD
Diclofenac—Dry mouth—Temozolomide—melanoma	9.32e-05	0.00106	CcSEcCtD
Diclofenac—Stomatitis—Docetaxel—melanoma	9.29e-05	0.00105	CcSEcCtD
Diclofenac—Jaundice—Docetaxel—melanoma	9.29e-05	0.00105	CcSEcCtD
Diclofenac—Pain—Bleomycin—melanoma	9.26e-05	0.00105	CcSEcCtD
Diclofenac—Conjunctivitis—Docetaxel—melanoma	9.26e-05	0.00105	CcSEcCtD
Diclofenac—Thrombocytopenia—Carmustine—melanoma	9.26e-05	0.00105	CcSEcCtD
Diclofenac—Tachycardia—Carmustine—melanoma	9.23e-05	0.00105	CcSEcCtD
Diclofenac—Confusional state—Temozolomide—melanoma	9.21e-05	0.00104	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Dactinomycin—melanoma	9.2e-05	0.00104	CcSEcCtD
Diclofenac—Anaphylactic shock—Temozolomide—melanoma	9.14e-05	0.00104	CcSEcCtD
Diclofenac—Oedema—Temozolomide—melanoma	9.14e-05	0.00104	CcSEcCtD
Diclofenac—Infection—Temozolomide—melanoma	9.08e-05	0.00103	CcSEcCtD
Diclofenac—PTGS2—head—melanoma	9.02e-05	0.00528	CbGeAlD
Diclofenac—Anorexia—Carmustine—melanoma	9.01e-05	0.00102	CcSEcCtD
Diclofenac—Hepatobiliary disease—Docetaxel—melanoma	9.01e-05	0.00102	CcSEcCtD
Diclofenac—Epistaxis—Docetaxel—melanoma	8.99e-05	0.00102	CcSEcCtD
Diclofenac—Nervous system disorder—Temozolomide—melanoma	8.96e-05	0.00102	CcSEcCtD
Diclofenac—Thrombocytopenia—Temozolomide—melanoma	8.95e-05	0.00101	CcSEcCtD
Diclofenac—Feeling abnormal—Bleomycin—melanoma	8.93e-05	0.00101	CcSEcCtD
Diclofenac—Agranulocytosis—Docetaxel—melanoma	8.89e-05	0.00101	CcSEcCtD
Diclofenac—Skin disorder—Temozolomide—melanoma	8.88e-05	0.00101	CcSEcCtD
Diclofenac—Hypotension—Carmustine—melanoma	8.83e-05	0.001	CcSEcCtD
Diclofenac—Hyperhidrosis—Temozolomide—melanoma	8.83e-05	0.001	CcSEcCtD
Diclofenac—Decreased appetite—Dactinomycin—melanoma	8.78e-05	0.000995	CcSEcCtD
Diclofenac—Fatigue—Dactinomycin—melanoma	8.71e-05	0.000987	CcSEcCtD
Diclofenac—Anorexia—Temozolomide—melanoma	8.71e-05	0.000987	CcSEcCtD
Diclofenac—Pain—Dactinomycin—melanoma	8.64e-05	0.000979	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Carmustine—melanoma	8.61e-05	0.000976	CcSEcCtD
Diclofenac—Urticaria—Bleomycin—melanoma	8.61e-05	0.000975	CcSEcCtD
Diclofenac—Haemoglobin—Docetaxel—melanoma	8.6e-05	0.000974	CcSEcCtD
Diclofenac—Rhinitis—Docetaxel—melanoma	8.57e-05	0.000972	CcSEcCtD
Diclofenac—Body temperature increased—Bleomycin—melanoma	8.56e-05	0.000971	CcSEcCtD
Diclofenac—Haemorrhage—Docetaxel—melanoma	8.55e-05	0.000969	CcSEcCtD
Diclofenac—Hepatitis—Docetaxel—melanoma	8.55e-05	0.000969	CcSEcCtD
Diclofenac—Insomnia—Carmustine—melanoma	8.55e-05	0.000969	CcSEcCtD
Diclofenac—Hypoaesthesia—Docetaxel—melanoma	8.51e-05	0.000965	CcSEcCtD
Diclofenac—Paraesthesia—Carmustine—melanoma	8.49e-05	0.000962	CcSEcCtD
Diclofenac—Pharyngitis—Docetaxel—melanoma	8.49e-05	0.000962	CcSEcCtD
Diclofenac—Urinary tract disorder—Docetaxel—melanoma	8.45e-05	0.000957	CcSEcCtD
Diclofenac—Dyspnoea—Carmustine—melanoma	8.43e-05	0.000955	CcSEcCtD
Diclofenac—Oedema peripheral—Docetaxel—melanoma	8.43e-05	0.000955	CcSEcCtD
Diclofenac—Somnolence—Carmustine—melanoma	8.41e-05	0.000953	CcSEcCtD
Diclofenac—Urethral disorder—Docetaxel—melanoma	8.38e-05	0.00095	CcSEcCtD
Diclofenac—Feeling abnormal—Dactinomycin—melanoma	8.32e-05	0.000944	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Temozolomide—melanoma	8.32e-05	0.000944	CcSEcCtD
Diclofenac—Insomnia—Temozolomide—melanoma	8.26e-05	0.000937	CcSEcCtD
Diclofenac—Gastrointestinal pain—Dactinomycin—melanoma	8.26e-05	0.000936	CcSEcCtD
Diclofenac—Visual impairment—Docetaxel—melanoma	8.24e-05	0.000934	CcSEcCtD
Diclofenac—Decreased appetite—Carmustine—melanoma	8.22e-05	0.000932	CcSEcCtD
Diclofenac—Paraesthesia—Temozolomide—melanoma	8.2e-05	0.00093	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Carmustine—melanoma	8.16e-05	0.000925	CcSEcCtD
Diclofenac—Dyspnoea—Temozolomide—melanoma	8.15e-05	0.000923	CcSEcCtD
Diclofenac—Somnolence—Temozolomide—melanoma	8.12e-05	0.000921	CcSEcCtD
Diclofenac—Erythema multiforme—Docetaxel—melanoma	8.09e-05	0.000917	CcSEcCtD
Diclofenac—Constipation—Carmustine—melanoma	8.09e-05	0.000916	CcSEcCtD
Diclofenac—Pain—Carmustine—melanoma	8.09e-05	0.000916	CcSEcCtD
Diclofenac—Dyspepsia—Temozolomide—melanoma	8.04e-05	0.000912	CcSEcCtD
Diclofenac—Eye disorder—Docetaxel—melanoma	7.99e-05	0.000906	CcSEcCtD
Diclofenac—Abdominal pain—Dactinomycin—melanoma	7.99e-05	0.000905	CcSEcCtD
Diclofenac—Body temperature increased—Dactinomycin—melanoma	7.99e-05	0.000905	CcSEcCtD
Diclofenac—Hypersensitivity—Bleomycin—melanoma	7.98e-05	0.000905	CcSEcCtD
Diclofenac—Decreased appetite—Temozolomide—melanoma	7.94e-05	0.0009	CcSEcCtD
Diclofenac—Cardiac disorder—Docetaxel—melanoma	7.94e-05	0.0009	CcSEcCtD
Diclofenac—Flushing—Docetaxel—melanoma	7.94e-05	0.0009	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Temozolomide—melanoma	7.89e-05	0.000894	CcSEcCtD
Diclofenac—Fatigue—Temozolomide—melanoma	7.88e-05	0.000893	CcSEcCtD
Diclofenac—Constipation—Temozolomide—melanoma	7.81e-05	0.000886	CcSEcCtD
Diclofenac—Pain—Temozolomide—melanoma	7.81e-05	0.000886	CcSEcCtD
Diclofenac—ABCB1—mammalian vulva—melanoma	7.8e-05	0.00457	CbGeAlD
Diclofenac—Feeling abnormal—Carmustine—melanoma	7.79e-05	0.000883	CcSEcCtD
Diclofenac—Asthenia—Bleomycin—melanoma	7.77e-05	0.000881	CcSEcCtD
Diclofenac—Angiopathy—Docetaxel—melanoma	7.76e-05	0.00088	CcSEcCtD
Diclofenac—Gastrointestinal pain—Carmustine—melanoma	7.73e-05	0.000876	CcSEcCtD
Diclofenac—Immune system disorder—Docetaxel—melanoma	7.73e-05	0.000876	CcSEcCtD
Diclofenac—Mediastinal disorder—Docetaxel—melanoma	7.71e-05	0.000874	CcSEcCtD
Diclofenac—Chills—Docetaxel—melanoma	7.67e-05	0.00087	CcSEcCtD
Diclofenac—Pruritus—Bleomycin—melanoma	7.66e-05	0.000869	CcSEcCtD
Diclofenac—Arrhythmia—Docetaxel—melanoma	7.64e-05	0.000866	CcSEcCtD
Diclofenac—Alopecia—Docetaxel—melanoma	7.56e-05	0.000857	CcSEcCtD
Diclofenac—Feeling abnormal—Temozolomide—melanoma	7.53e-05	0.000853	CcSEcCtD
Diclofenac—CYP1A1—lymph node—melanoma	7.52e-05	0.0044	CbGeAlD
Diclofenac—Mental disorder—Docetaxel—melanoma	7.49e-05	0.000849	CcSEcCtD
Diclofenac—Body temperature increased—Carmustine—melanoma	7.47e-05	0.000847	CcSEcCtD
Diclofenac—Abdominal pain—Carmustine—melanoma	7.47e-05	0.000847	CcSEcCtD
Diclofenac—Gastrointestinal pain—Temozolomide—melanoma	7.47e-05	0.000847	CcSEcCtD
Diclofenac—Malnutrition—Docetaxel—melanoma	7.45e-05	0.000844	CcSEcCtD
Diclofenac—Erythema—Docetaxel—melanoma	7.45e-05	0.000844	CcSEcCtD
Diclofenac—Hypersensitivity—Dactinomycin—melanoma	7.44e-05	0.000844	CcSEcCtD
Diclofenac—Dysgeusia—Docetaxel—melanoma	7.29e-05	0.000826	CcSEcCtD
Diclofenac—Urticaria—Temozolomide—melanoma	7.26e-05	0.000823	CcSEcCtD
Diclofenac—Asthenia—Dactinomycin—melanoma	7.25e-05	0.000822	CcSEcCtD
Diclofenac—Abdominal pain—Temozolomide—melanoma	7.22e-05	0.000819	CcSEcCtD
Diclofenac—Body temperature increased—Temozolomide—melanoma	7.22e-05	0.000819	CcSEcCtD
Diclofenac—Back pain—Docetaxel—melanoma	7.2e-05	0.000816	CcSEcCtD
Diclofenac—Muscle spasms—Docetaxel—melanoma	7.16e-05	0.000811	CcSEcCtD
Diclofenac—Hypersensitivity—Carmustine—melanoma	6.97e-05	0.00079	CcSEcCtD
Diclofenac—Diarrhoea—Dactinomycin—melanoma	6.91e-05	0.000783	CcSEcCtD
Diclofenac—Vomiting—Bleomycin—melanoma	6.89e-05	0.000781	CcSEcCtD
Diclofenac—Anaemia—Docetaxel—melanoma	6.88e-05	0.00078	CcSEcCtD
Diclofenac—Rash—Bleomycin—melanoma	6.83e-05	0.000774	CcSEcCtD
Diclofenac—Dermatitis—Bleomycin—melanoma	6.82e-05	0.000773	CcSEcCtD
Diclofenac—Asthenia—Carmustine—melanoma	6.78e-05	0.000769	CcSEcCtD
Diclofenac—Hypersensitivity—Temozolomide—melanoma	6.73e-05	0.000763	CcSEcCtD
Diclofenac—Syncope—Docetaxel—melanoma	6.68e-05	0.000757	CcSEcCtD
Diclofenac—Leukopenia—Docetaxel—melanoma	6.66e-05	0.000755	CcSEcCtD
Diclofenac—PTGS1—lymph node—melanoma	6.61e-05	0.00387	CbGeAlD
Diclofenac—Palpitations—Docetaxel—melanoma	6.58e-05	0.000746	CcSEcCtD
Diclofenac—Asthenia—Temozolomide—melanoma	6.56e-05	0.000743	CcSEcCtD
Diclofenac—Loss of consciousness—Docetaxel—melanoma	6.54e-05	0.000742	CcSEcCtD
Diclofenac—Cough—Docetaxel—melanoma	6.5e-05	0.000736	CcSEcCtD
Diclofenac—Diarrhoea—Carmustine—melanoma	6.47e-05	0.000733	CcSEcCtD
Diclofenac—Pruritus—Temozolomide—melanoma	6.46e-05	0.000733	CcSEcCtD
Diclofenac—Convulsion—Docetaxel—melanoma	6.45e-05	0.000731	CcSEcCtD
Diclofenac—Nausea—Bleomycin—melanoma	6.43e-05	0.000729	CcSEcCtD
Diclofenac—Hypertension—Docetaxel—melanoma	6.43e-05	0.000729	CcSEcCtD
Diclofenac—Vomiting—Dactinomycin—melanoma	6.42e-05	0.000728	CcSEcCtD
Diclofenac—Rash—Dactinomycin—melanoma	6.37e-05	0.000722	CcSEcCtD
Diclofenac—Myalgia—Docetaxel—melanoma	6.34e-05	0.000718	CcSEcCtD
Diclofenac—Arthralgia—Docetaxel—melanoma	6.34e-05	0.000718	CcSEcCtD
Diclofenac—Chest pain—Docetaxel—melanoma	6.34e-05	0.000718	CcSEcCtD
Diclofenac—PTGS2—lymph node—melanoma	6.31e-05	0.0037	CbGeAlD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	6.29e-05	0.000713	CcSEcCtD
Diclofenac—Dizziness—Carmustine—melanoma	6.25e-05	0.000709	CcSEcCtD
Diclofenac—Diarrhoea—Temozolomide—melanoma	6.25e-05	0.000709	CcSEcCtD
Diclofenac—Dry mouth—Docetaxel—melanoma	6.2e-05	0.000703	CcSEcCtD
Diclofenac—Confusional state—Docetaxel—melanoma	6.13e-05	0.000694	CcSEcCtD
Diclofenac—Anaphylactic shock—Docetaxel—melanoma	6.08e-05	0.000689	CcSEcCtD
Diclofenac—Oedema—Docetaxel—melanoma	6.08e-05	0.000689	CcSEcCtD
Diclofenac—Dizziness—Temozolomide—melanoma	6.04e-05	0.000685	CcSEcCtD
Diclofenac—Infection—Docetaxel—melanoma	6.04e-05	0.000684	CcSEcCtD
Diclofenac—Vomiting—Carmustine—melanoma	6.01e-05	0.000681	CcSEcCtD
Diclofenac—Nausea—Dactinomycin—melanoma	6e-05	0.00068	CcSEcCtD
Diclofenac—Shock—Docetaxel—melanoma	5.98e-05	0.000678	CcSEcCtD
Diclofenac—Rash—Carmustine—melanoma	5.96e-05	0.000676	CcSEcCtD
Diclofenac—Nervous system disorder—Docetaxel—melanoma	5.96e-05	0.000675	CcSEcCtD
Diclofenac—Dermatitis—Carmustine—melanoma	5.96e-05	0.000675	CcSEcCtD
Diclofenac—Thrombocytopenia—Docetaxel—melanoma	5.95e-05	0.000674	CcSEcCtD
Diclofenac—Tachycardia—Docetaxel—melanoma	5.93e-05	0.000672	CcSEcCtD
Diclofenac—Headache—Carmustine—melanoma	5.92e-05	0.000671	CcSEcCtD
Diclofenac—Skin disorder—Docetaxel—melanoma	5.9e-05	0.000669	CcSEcCtD
Diclofenac—Vomiting—Temozolomide—melanoma	5.81e-05	0.000658	CcSEcCtD
Diclofenac—Anorexia—Docetaxel—melanoma	5.79e-05	0.000656	CcSEcCtD
Diclofenac—Rash—Temozolomide—melanoma	5.76e-05	0.000653	CcSEcCtD
Diclofenac—Dermatitis—Temozolomide—melanoma	5.76e-05	0.000652	CcSEcCtD
Diclofenac—Headache—Temozolomide—melanoma	5.72e-05	0.000649	CcSEcCtD
Diclofenac—Hypotension—Docetaxel—melanoma	5.68e-05	0.000644	CcSEcCtD
Diclofenac—Nausea—Carmustine—melanoma	5.62e-05	0.000637	CcSEcCtD
Diclofenac—ABCB1—head—melanoma	5.58e-05	0.00327	CbGeAlD
Diclofenac—Musculoskeletal discomfort—Docetaxel—melanoma	5.54e-05	0.000627	CcSEcCtD
Diclofenac—Insomnia—Docetaxel—melanoma	5.5e-05	0.000623	CcSEcCtD
Diclofenac—Paraesthesia—Docetaxel—melanoma	5.46e-05	0.000618	CcSEcCtD
Diclofenac—Nausea—Temozolomide—melanoma	5.43e-05	0.000615	CcSEcCtD
Diclofenac—Dyspnoea—Docetaxel—melanoma	5.42e-05	0.000614	CcSEcCtD
Diclofenac—Somnolence—Docetaxel—melanoma	5.4e-05	0.000612	CcSEcCtD
Diclofenac—Dyspepsia—Docetaxel—melanoma	5.35e-05	0.000606	CcSEcCtD
Diclofenac—Decreased appetite—Docetaxel—melanoma	5.28e-05	0.000599	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Docetaxel—melanoma	5.25e-05	0.000595	CcSEcCtD
Diclofenac—Fatigue—Docetaxel—melanoma	5.24e-05	0.000594	CcSEcCtD
Diclofenac—Pain—Docetaxel—melanoma	5.2e-05	0.000589	CcSEcCtD
Diclofenac—Constipation—Docetaxel—melanoma	5.2e-05	0.000589	CcSEcCtD
Diclofenac—Feeling abnormal—Docetaxel—melanoma	5.01e-05	0.000568	CcSEcCtD
Diclofenac—Gastrointestinal pain—Docetaxel—melanoma	4.97e-05	0.000563	CcSEcCtD
Diclofenac—Abdominal pain—Docetaxel—melanoma	4.8e-05	0.000544	CcSEcCtD
Diclofenac—Body temperature increased—Docetaxel—melanoma	4.8e-05	0.000544	CcSEcCtD
Diclofenac—Hypersensitivity—Docetaxel—melanoma	4.48e-05	0.000507	CcSEcCtD
Diclofenac—Asthenia—Docetaxel—melanoma	4.36e-05	0.000494	CcSEcCtD
Diclofenac—Pruritus—Docetaxel—melanoma	4.3e-05	0.000487	CcSEcCtD
Diclofenac—Diarrhoea—Docetaxel—melanoma	4.16e-05	0.000471	CcSEcCtD
Diclofenac—Dizziness—Docetaxel—melanoma	4.02e-05	0.000455	CcSEcCtD
Diclofenac—ABCB1—lymph node—melanoma	3.91e-05	0.00229	CbGeAlD
Diclofenac—Vomiting—Docetaxel—melanoma	3.86e-05	0.000438	CcSEcCtD
Diclofenac—Rash—Docetaxel—melanoma	3.83e-05	0.000434	CcSEcCtD
Diclofenac—Dermatitis—Docetaxel—melanoma	3.83e-05	0.000434	CcSEcCtD
Diclofenac—Headache—Docetaxel—melanoma	3.81e-05	0.000431	CcSEcCtD
Diclofenac—Nausea—Docetaxel—melanoma	3.61e-05	0.000409	CcSEcCtD
Diclofenac—PTGS2—Disease—NOTCH1—melanoma	1.88e-06	1.8e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ERCC2—melanoma	1.87e-06	1.8e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PPARG—melanoma	1.87e-06	1.79e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.86e-06	1.78e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CTNNB1—melanoma	1.86e-06	1.78e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—SLC5A5—melanoma	1.85e-06	1.78e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.85e-06	1.77e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PRKCA—melanoma	1.85e-06	1.77e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CD80—melanoma	1.84e-06	1.76e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP1B1—melanoma	1.84e-06	1.76e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—APC—melanoma	1.84e-06	1.76e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KIT—melanoma	1.84e-06	1.76e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—VEGFA—melanoma	1.83e-06	1.76e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ERCC2—melanoma	1.83e-06	1.76e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CB—melanoma	1.82e-06	1.75e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—CDKN1A—melanoma	1.82e-06	1.74e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGF—melanoma	1.81e-06	1.74e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—NRAS—melanoma	1.81e-06	1.74e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PTEN—melanoma	1.81e-06	1.74e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IL6—melanoma	1.81e-06	1.74e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTGS2—melanoma	1.8e-06	1.73e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GNAQ—melanoma	1.79e-06	1.72e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CD44—melanoma	1.79e-06	1.72e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PLA2G6—melanoma	1.77e-06	1.7e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CB—melanoma	1.76e-06	1.68e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—VEGFA—melanoma	1.76e-06	1.68e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.75e-06	1.68e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PRKCA—melanoma	1.74e-06	1.67e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP17A1—melanoma	1.74e-06	1.67e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTGS2—melanoma	1.74e-06	1.67e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—STAT3—melanoma	1.74e-06	1.67e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.74e-06	1.67e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—MAPK3—melanoma	1.74e-06	1.67e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ABCB1—melanoma	1.74e-06	1.66e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—NRAS—melanoma	1.73e-06	1.66e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ERCC2—melanoma	1.73e-06	1.66e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—BRAF—melanoma	1.73e-06	1.66e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—ABCB1—melanoma	1.73e-06	1.66e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	1.72e-06	1.65e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP1B1—melanoma	1.72e-06	1.65e-05	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—AKT1—melanoma	1.7e-06	1.64e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CD—melanoma	1.7e-06	1.63e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	1.7e-06	1.63e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—ALB—melanoma	1.68e-06	1.61e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AKT1—melanoma	1.67e-06	1.6e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MAPK3—melanoma	1.66e-06	1.59e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.66e-06	1.59e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—MAPK1—melanoma	1.65e-06	1.58e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GNA11—melanoma	1.64e-06	1.58e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MAP2K1—melanoma	1.62e-06	1.56e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—STAT3—melanoma	1.62e-06	1.55e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NRAS—melanoma	1.62e-06	1.55e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MYC—melanoma	1.61e-06	1.55e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CD—melanoma	1.61e-06	1.55e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.61e-06	1.55e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—FASN—melanoma	1.61e-06	1.54e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PRKCA—melanoma	1.6e-06	1.53e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—VCAN—melanoma	1.59e-06	1.53e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PRKCA—melanoma	1.59e-06	1.52e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ERCC2—melanoma	1.58e-06	1.52e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—SLC5A5—melanoma	1.58e-06	1.52e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MAPK1—melanoma	1.58e-06	1.52e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EGFR—melanoma	1.58e-06	1.52e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—ERCC2—melanoma	1.57e-06	1.51e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTEN—melanoma	1.57e-06	1.51e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—KRAS—melanoma	1.56e-06	1.5e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ABCB1—melanoma	1.55e-06	1.49e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MAPK3—melanoma	1.55e-06	1.48e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—FGF2—melanoma	1.55e-06	1.48e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CG—melanoma	1.54e-06	1.48e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GNAQ—melanoma	1.53e-06	1.47e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CD44—melanoma	1.53e-06	1.47e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTEN—melanoma	1.52e-06	1.46e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.51e-06	1.45e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MYC—melanoma	1.51e-06	1.44e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	1.5e-06	1.44e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—KRAS—melanoma	1.49e-06	1.43e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CB—melanoma	1.48e-06	1.42e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PPARG—melanoma	1.48e-06	1.42e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	1.48e-06	1.42e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CG—melanoma	1.48e-06	1.42e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MAPK1—melanoma	1.47e-06	1.41e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EGFR—melanoma	1.47e-06	1.41e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTGS2—melanoma	1.47e-06	1.41e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP1B1—melanoma	1.47e-06	1.41e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CG—melanoma	1.45e-06	1.39e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MDM2—melanoma	1.45e-06	1.39e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PIK3CA—melanoma	1.43e-06	1.37e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.43e-06	1.37e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PPARG—melanoma	1.43e-06	1.37e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PRKCA—melanoma	1.43e-06	1.37e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—ERBB2—melanoma	1.43e-06	1.37e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ERCC2—melanoma	1.41e-06	1.36e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ABCB1—melanoma	1.41e-06	1.36e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CB—melanoma	1.41e-06	1.35e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CD4—melanoma	1.4e-06	1.35e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PIK3CA—melanoma	1.4e-06	1.35e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PPARG—melanoma	1.4e-06	1.34e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PRKCA—melanoma	1.39e-06	1.33e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—KRAS—melanoma	1.39e-06	1.33e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—melanoma	1.39e-06	1.33e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ERCC2—melanoma	1.38e-06	1.32e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PIK3CA—melanoma	1.37e-06	1.32e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PIK3CA—melanoma	1.37e-06	1.31e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CG—melanoma	1.36e-06	1.31e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CD—melanoma	1.35e-06	1.3e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP17A1—melanoma	1.34e-06	1.29e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—ALB—melanoma	1.33e-06	1.28e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—melanoma	1.33e-06	1.27e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HRAS—melanoma	1.33e-06	1.27e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1B—melanoma	1.32e-06	1.27e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PPARG—melanoma	1.32e-06	1.26e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.31e-06	1.26e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.3e-06	1.25e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PRKCA—melanoma	1.3e-06	1.25e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CD—melanoma	1.3e-06	1.25e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.29e-06	1.24e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ERCC2—melanoma	1.29e-06	1.24e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—ALB—melanoma	1.28e-06	1.23e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTEN—melanoma	1.28e-06	1.23e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PIK3CA—melanoma	1.28e-06	1.23e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CD—melanoma	1.27e-06	1.22e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GNA11—melanoma	1.27e-06	1.22e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HRAS—melanoma	1.27e-06	1.22e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—ALB—melanoma	1.26e-06	1.2e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CG—melanoma	1.25e-06	1.2e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CTNNB1—melanoma	1.25e-06	1.2e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CG—melanoma	1.24e-06	1.19e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—FASN—melanoma	1.24e-06	1.19e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—SLC5A5—melanoma	1.22e-06	1.17e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—CDKN1A—melanoma	1.22e-06	1.17e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PTEN—melanoma	1.22e-06	1.17e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL6—melanoma	1.21e-06	1.16e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PPARG—melanoma	1.21e-06	1.16e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ABCB1—melanoma	1.21e-06	1.16e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PPARG—melanoma	1.2e-06	1.15e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CD—melanoma	1.2e-06	1.15e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—ALB—melanoma	1.18e-06	1.14e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HRAS—melanoma	1.18e-06	1.13e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GNAQ—melanoma	1.18e-06	1.13e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CD44—melanoma	1.18e-06	1.13e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CB—melanoma	1.18e-06	1.13e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.17e-06	1.12e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—AKT1—melanoma	1.17e-06	1.12e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AKT1—melanoma	1.15e-06	1.1e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CB—melanoma	1.13e-06	1.09e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—IL6—melanoma	1.13e-06	1.09e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP1B1—melanoma	1.13e-06	1.09e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTGS2—melanoma	1.12e-06	1.08e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AKT1—melanoma	1.12e-06	1.07e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CG—melanoma	1.12e-06	1.07e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AKT1—melanoma	1.12e-06	1.07e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PRKCA—melanoma	1.11e-06	1.07e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CA—melanoma	1.11e-06	1.06e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CB—melanoma	1.11e-06	1.06e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ERCC2—melanoma	1.1e-06	1.06e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CD—melanoma	1.1e-06	1.06e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTGS2—melanoma	1.1e-06	1.05e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CD—melanoma	1.09e-06	1.05e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CG—melanoma	1.09e-06	1.05e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—STAT3—melanoma	1.09e-06	1.04e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—ALB—melanoma	1.09e-06	1.04e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NRAS—melanoma	1.08e-06	1.04e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PPARG—melanoma	1.08e-06	1.03e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CA—melanoma	1.07e-06	1.03e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.07e-06	1.02e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PPARG—melanoma	1.05e-06	1.01e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CB—melanoma	1.05e-06	1e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—AKT1—melanoma	1.04e-06	1e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MAPK3—melanoma	1.04e-06	9.96e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTGS2—melanoma	1.04e-06	9.94e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CG—melanoma	1.02e-06	9.77e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PTEN—melanoma	1.02e-06	9.77e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MYC—melanoma	1.01e-06	9.69e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MAPK1—melanoma	9.88e-07	9.48e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGFR—melanoma	9.88e-07	9.48e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PPARG—melanoma	9.83e-07	9.43e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CD—melanoma	9.82e-07	9.42e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTEN—melanoma	9.78e-07	9.39e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—ALB—melanoma	9.69e-07	9.3e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CB—melanoma	9.59e-07	9.2e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTEN—melanoma	9.58e-07	9.19e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CD—melanoma	9.58e-07	9.19e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CB—melanoma	9.53e-07	9.14e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTGS2—melanoma	9.5e-07	9.11e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—ALB—melanoma	9.46e-07	9.07e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTGS2—melanoma	9.44e-07	9.06e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—KRAS—melanoma	9.33e-07	8.95e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ABCB1—melanoma	9.31e-07	8.94e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	9.13e-07	8.75e-06	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AKT1—melanoma	9.07e-07	8.7e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CA—melanoma	9.05e-07	8.68e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTEN—melanoma	9.03e-07	8.67e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CD—melanoma	8.95e-07	8.59e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—ALB—melanoma	8.84e-07	8.48e-06	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AKT1—melanoma	8.74e-07	8.39e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CG—melanoma	8.7e-07	8.35e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CA—melanoma	8.57e-07	8.23e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PRKCA—melanoma	8.57e-07	8.22e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CB—melanoma	8.56e-07	8.21e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ERCC2—melanoma	8.5e-07	8.16e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTGS2—melanoma	8.48e-07	8.13e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PPARG—melanoma	8.4e-07	8.06e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CB—melanoma	8.35e-07	8.01e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTEN—melanoma	8.28e-07	7.95e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTGS2—melanoma	8.27e-07	7.94e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTEN—melanoma	8.24e-07	7.9e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HRAS—melanoma	7.93e-07	7.61e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CB—melanoma	7.8e-07	7.48e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTGS2—melanoma	7.73e-07	7.42e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CD—melanoma	7.65e-07	7.34e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—IL6—melanoma	7.59e-07	7.29e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—ALB—melanoma	7.55e-07	7.24e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTEN—melanoma	7.39e-07	7.09e-06	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AKT1—melanoma	7.39e-07	7.09e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTEN—melanoma	7.22e-07	6.92e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CA—melanoma	7.18e-07	6.89e-06	CbGpPWpGaD
Diclofenac—PTGS2—Disease—AKT1—melanoma	7e-07	6.72e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CA—melanoma	6.9e-07	6.62e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CA—melanoma	6.76e-07	6.49e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTEN—melanoma	6.74e-07	6.47e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CG—melanoma	6.71e-07	6.44e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CB—melanoma	6.67e-07	6.4e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTGS2—melanoma	6.61e-07	6.34e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PPARG—melanoma	6.48e-07	6.22e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CA—melanoma	6.37e-07	6.11e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CD—melanoma	5.9e-07	5.66e-06	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AKT1—melanoma	5.87e-07	5.63e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CA—melanoma	5.84e-07	5.61e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—ALB—melanoma	5.83e-07	5.59e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CA—melanoma	5.81e-07	5.57e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTEN—melanoma	5.76e-07	5.53e-06	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AKT1—melanoma	5.64e-07	5.41e-06	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AKT1—melanoma	5.52e-07	5.3e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CA—melanoma	5.22e-07	5e-06	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AKT1—melanoma	5.21e-07	5e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CB—melanoma	5.14e-07	4.94e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS2—melanoma	5.1e-07	4.89e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CA—melanoma	5.09e-07	4.88e-06	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AKT1—melanoma	4.77e-07	4.58e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CA—melanoma	4.76e-07	4.56e-06	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AKT1—melanoma	4.75e-07	4.55e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTEN—melanoma	4.45e-07	4.27e-06	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKT1—melanoma	4.26e-07	4.09e-06	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKT1—melanoma	4.16e-07	3.99e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CA—melanoma	4.06e-07	3.9e-06	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKT1—melanoma	3.88e-07	3.73e-06	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKT1—melanoma	3.32e-07	3.19e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CA—melanoma	3.14e-07	3.01e-06	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKT1—melanoma	2.56e-07	2.46e-06	CbGpPWpGaD
